@article{Nicolo2022,
abstract = {Ritonavir-boosted darunavir (DRV/r) and dolutegravir (DTG) are affected by induction of metabolizing enzymes and efflux transporters caused by rifampicin (RIF). This complicates the treatment of pe...},
author = {{De Nicol{\`{o}}}, Amedeo and Calcagno, Andrea and Motta, Ilaria and Vivo, Elisa De and D'Avolio, Antonio and Perri, Giovanni Di and Wiesner, Lubbe and Ebrahim, Isma-eel and Maartens, Gary and Orrell, Catherine and McIlleron, Helen},
doi = {10.1128/AAC.00136-22},
file = {:C$\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/De Nicol{\`{o}} et al. - 2022 - The effect of rifampicin on darunavir, ritonavir, and dolutegravir exposure within peripheral blood mononuclea.pdf:pdf},
issn = {0066-4804},
journal = {Antimicrobial Agents and Chemotherapy},
keywords = {OA,PBMC,darunavir,dolutegravir,drug interactions,drug-drug interaction,fund{\_}not{\_}ack,original,pharmacokinetics,rifampicin},
mendeley-tags = {OA,fund{\_}not{\_}ack,original},
month = {may},
number = {6},
pages = {e0013622},
pmid = {35583344},
publisher = {American Society for Microbiology 1752 N St., N.W., Washington, DC},
title = {{The effect of rifampicin on darunavir, ritonavir, and dolutegravir exposure within peripheral blood mononuclear cells: a dose escalation study}},
url = {https://journals.asm.org/doi/full/10.1128/aac.00136-22},
volume = {66},
year = {2022}
}

{"_id":"qKLFmcarEvyYsJCw4","bibbaseid":"denicol-calcagno-motta-vivo-davolio-perri-wiesner-ebrahim-etal-theeffectofrifampicinondarunavirritonaviranddolutegravirexposurewithinperipheralbloodmononuclearcellsadoseescalationstudy-2022","author_short":["De Nicolò, A.","Calcagno, A.","Motta, I.","Vivo, E. D.","D'Avolio, A.","Perri, G. D.","Wiesner, L.","Ebrahim, I.","Maartens, G.","Orrell, C.","McIlleron, H."],"bibdata":{"bibtype":"article","type":"article","abstract":"Ritonavir-boosted darunavir (DRV/r) and dolutegravir (DTG) are affected by induction of metabolizing enzymes and efflux transporters caused by rifampicin (RIF). This complicates the treatment of pe...","author":[{"propositions":[],"lastnames":["De Nicolò"],"firstnames":["Amedeo"],"suffixes":[]},{"propositions":[],"lastnames":["Calcagno"],"firstnames":["Andrea"],"suffixes":[]},{"propositions":[],"lastnames":["Motta"],"firstnames":["Ilaria"],"suffixes":[]},{"propositions":[],"lastnames":["Vivo"],"firstnames":["Elisa","De"],"suffixes":[]},{"propositions":[],"lastnames":["D'Avolio"],"firstnames":["Antonio"],"suffixes":[]},{"propositions":[],"lastnames":["Perri"],"firstnames":["Giovanni","Di"],"suffixes":[]},{"propositions":[],"lastnames":["Wiesner"],"firstnames":["Lubbe"],"suffixes":[]},{"propositions":[],"lastnames":["Ebrahim"],"firstnames":["Isma-eel"],"suffixes":[]},{"propositions":[],"lastnames":["Maartens"],"firstnames":["Gary"],"suffixes":[]},{"propositions":[],"lastnames":["Orrell"],"firstnames":["Catherine"],"suffixes":[]},{"propositions":[],"lastnames":["McIlleron"],"firstnames":["Helen"],"suffixes":[]}],"doi":"10.1128/AAC.00136-22","file":":C$\\$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/De Nicolò et al. - 2022 - The effect of rifampicin on darunavir, ritonavir, and dolutegravir exposure within peripheral blood mononuclea.pdf:pdf","issn":"0066-4804","journal":"Antimicrobial Agents and Chemotherapy","keywords":"OA,PBMC,darunavir,dolutegravir,drug interactions,drug-drug interaction,fund_not_ack,original,pharmacokinetics,rifampicin","mendeley-tags":"OA,fund_not_ack,original","month":"may","number":"6","pages":"e0013622","pmid":"35583344","publisher":"American Society for Microbiology 1752 N St., N.W., Washington, DC","title":"The effect of rifampicin on darunavir, ritonavir, and dolutegravir exposure within peripheral blood mononuclear cells: a dose escalation study","url":"https://journals.asm.org/doi/full/10.1128/aac.00136-22","volume":"66","year":"2022","bibtex":"@article{Nicolo2022,\r\nabstract = {Ritonavir-boosted darunavir (DRV/r) and dolutegravir (DTG) are affected by induction of metabolizing enzymes and efflux transporters caused by rifampicin (RIF). This complicates the treatment of pe...},\r\nauthor = {{De Nicol{\\`{o}}}, Amedeo and Calcagno, Andrea and Motta, Ilaria and Vivo, Elisa De and D'Avolio, Antonio and Perri, Giovanni Di and Wiesner, Lubbe and Ebrahim, Isma-eel and Maartens, Gary and Orrell, Catherine and McIlleron, Helen},\r\ndoi = {10.1128/AAC.00136-22},\r\nfile = {:C$\\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/De Nicol{\\`{o}} et al. - 2022 - The effect of rifampicin on darunavir, ritonavir, and dolutegravir exposure within peripheral blood mononuclea.pdf:pdf},\r\nissn = {0066-4804},\r\njournal = {Antimicrobial Agents and Chemotherapy},\r\nkeywords = {OA,PBMC,darunavir,dolutegravir,drug interactions,drug-drug interaction,fund{\\_}not{\\_}ack,original,pharmacokinetics,rifampicin},\r\nmendeley-tags = {OA,fund{\\_}not{\\_}ack,original},\r\nmonth = {may},\r\nnumber = {6},\r\npages = {e0013622},\r\npmid = {35583344},\r\npublisher = {American Society for Microbiology 1752 N St., N.W., Washington, DC},\r\ntitle = {{The effect of rifampicin on darunavir, ritonavir, and dolutegravir exposure within peripheral blood mononuclear cells: a dose escalation study}},\r\nurl = {https://journals.asm.org/doi/full/10.1128/aac.00136-22},\r\nvolume = {66},\r\nyear = {2022}\r\n}\r\n","author_short":["De Nicolò, A.","Calcagno, A.","Motta, I.","Vivo, E. D.","D'Avolio, A.","Perri, G. D.","Wiesner, L.","Ebrahim, I.","Maartens, G.","Orrell, C.","McIlleron, H."],"key":"Nicolo2022","id":"Nicolo2022","bibbaseid":"denicol-calcagno-motta-vivo-davolio-perri-wiesner-ebrahim-etal-theeffectofrifampicinondarunavirritonaviranddolutegravirexposurewithinperipheralbloodmononuclearcellsadoseescalationstudy-2022","role":"author","urls":{"Paper":"https://journals.asm.org/doi/full/10.1128/aac.00136-22"},"keyword":["OA","PBMC","darunavir","dolutegravir","drug interactions","drug-drug interaction","fund_not_ack","original","pharmacokinetics","rifampicin"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://drive.google.com/uc?export=download&id=1-JLqZ7RwZ3VC2d6ErLGHAtOeMRS_7GCz","dataSources":["Krmt6gt9ktB2s6ARh"],"keywords":["oa","pbmc","darunavir","dolutegravir","drug interactions","drug-drug interaction","fund_not_ack","original","pharmacokinetics","rifampicin"],"search_terms":["effect","rifampicin","darunavir","ritonavir","dolutegravir","exposure","within","peripheral","blood","mononuclear","cells","dose","escalation","study","de nicolò","calcagno","motta","vivo","d'avolio","perri","wiesner","ebrahim","maartens","orrell","mcilleron"],"title":"The effect of rifampicin on darunavir, ritonavir, and dolutegravir exposure within peripheral blood mononuclear cells: a dose escalation study","year":2022}